ȯÀÚÀÇ ¸¶À½±îÁö Ä¡À¯ÇÏ´Â º£Ã¼Æ®º´°ú Å»¸ð ºÐ¾ß ±ÇÀ§ÀÚ
| Á¦ ¸ñ | Å»¸ðÇÐ |
|---|---|
| ÃâÆÇ»ç | Á¤¿ìÀÇÇмÀû |
| ¹ßÇàÀÏ | 2021 |
| Á¦ ¸ñ | KIM's Dermatology |
|---|---|
| ÃâÆÇ»ç | Á¤¿ìÀÇÇмÀû |
| ¹ßÇàÀÏ | 2025 |
| Á¦ ¸ñ | Behçet¡¯s Disease: Progress in Recent Years and Unmet Needs for the Future |
|---|---|
| ÃâÆÇ»ç | Nova Science Publishers |
| ¹ßÇàÀÏ | 2015 |
| Á¦ ¸ñ | Atlas of Inflammatory Bowel Diseases |
|---|---|
| ÃâÆÇ»ç | Springer |
| ¹ßÇàÀÏ | 2015 |
| Á¦ ¸ñ | Behçet¡¯s Disease in Korea |
|---|---|
| ÃâÆÇ»ç | ÇÏ´©¸® |
| ¹ßÇàÀÏ | 2013 |
| Á¦ ¸ñ | Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | Nature Medicine |
| Á¦ ¸ñ | Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters |
|---|---|
| ¹ßÇ¥³âµµ | 2023 |
| ¹ßÇ¥Áö | Journal of Clinical Investigation |
| Á¦ ¸ñ | Core Gene Signatures of Atopic Dermatitis Using Public RNA-Sequencing Resources: Comparison of Bulk Approach with Single-Cell Approach |
|---|---|
| ¹ßÇ¥³âµµ | 2022 |
| ¹ßÇ¥Áö | Journal of Investigative Dermatology |
| Á¦ ¸ñ | Application of single-cell RNA sequencing on human skin: Technical evolution and challenges |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | Journal of Dermatological Science |
| Á¦ ¸ñ | Trial of apremilast for oral ulces in Behçet's syndrome |
|---|---|
| ¹ßÇ¥³âµµ | 2019 |
| ¹ßÇ¥Áö | New England Journal of Medicine |
| Á¦ ¸ñ | Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium |
|---|---|
| ¹ßÇ¥³âµµ | 2019 |
| ¹ßÇ¥Áö | Cell |
| Á¦ ¸ñ | Non-thermal atmospheric pressure plasma activates Wnt/¥â-catenin signaling in dermal papilla cells |
|---|---|
| ¹ßÇ¥³âµµ | 2021 |
| ¹ßÇ¥Áö | Scientific Reports |
´Ù¾çÇÑ Àü½ÅÁõ»ó°ú µ¿¹ÝµÈ ÇǺÎÁ¡¸·, ºÎ¼Ó±âÀÇ Ä§¹ü¿¡ ´ëÇØ ¸é¿ªÇÐÀûÀ¸·Î ¿¬±¸ÇÏ°í °ü·ÃÁúȯÀ» Áø·áÇϴµ¥ Çй®ÀûÀÎ °ü½ÉÀÌ ¸¹½À´Ï´Ù. ƯÈ÷ ´Ù¾çÇÑ Àå±âÁúȯÀ» ħ¹üÇÏ¸é¼ ±¸°±Ë¾çÀÌ ½ÉÇÑ º£Ã¼Æ®º´°ú ÀÚ°¡¸é¿ª±âÀüÀÇ Å»¸ð°¡ ÀϾ´Â ¿øÇüÅ»¸ð¿¡ ´ëÇØ ¿¬±¸¿Í Áø·á¸¦ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇǺÎÁ¡¸·À» Àß Ä§¹üÇÏ´Â ÁßÁõ¾à¹°¹ßÁøÀÇ Áø´Ü¹ý °³¹ß¿¡µµ ¿¬±¸¸¦ º´ÇàÇϰí ÀÖ¾î, ÁßÁõ¾àÁøÈ¯ÀÚÀÇ Áø·áµµ ´ã´çÇϰí ÀÖ½À´Ï´Ù.
´Ù¸¥ Áúȯµµ ¸¶Âù°¡Áö°ÚÁö¸¸, »õ·Î¿î ¿¬±¸¼º°úµéÀÌ ¸é¿ªÇǺÎÁúȯ¿¡¼´Â °è¼Ó ¾÷µ¥ÀÌÆ® µÇ°í ÀÖ°í, ÁúȯÁ¤Àǵµ °è¼Ó ´Þ¶óÁö°í ÀÖ½À´Ï´Ù. "¾Æ´Â¸¸Å º¸ÀδÙ"´Â Áø·áöÇеµ »õ·Î¿î Áö½Ä¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¾÷µ¥ÀÌÆ®°¡ ÀÌ·ç¾îÁ®¾ß Áø·áÀÇ ¿ª·®µµ ³ô¾ÆÁø´Ù°í »ý°¢ÇÕ´Ï´Ù. ¶ÇÇÑ Áß¿äÇÑ ÀÓ»ó Á¤º¸´Â ȯÀÚ¿¡°Ô¼ ³ª¿À´Â °ÍÀ¸¹Ç·Î ȯÀÚ°¡ Á¦°øÇÏ´Â Á¤º¸¸¦ Áø·á½Ã°£¿¡ °¡±ÞÀû ¸¹ÀÌ °æÃ»ÇϰíÀÚ ÇÕ´Ï´Ù.
º£Ã¼Æ®º´À̳ª ¿øÇüÅ»¸ð´Â ´Ü±â°£ Ä¡·á¿¡ ±Ý¹æ ¿ÏÄ¡µÇ´Â º´ÀÌ ¾Æ´Ï°í ÄÁµð¼Ç¿¡ µû¶ó ¸¸¼ºÀûÀ¸·Î Àç¹ßÇÏ´Â ÁúȯÀÔ´Ï´Ù. Áõ»ó¾ÇÈ¿¡ µû¸¥ Èûµë°ú ÁÂÀýÀÌ ÀÖ°ÚÁö¸¸ ±Þ¼º±â¸¦ Àß º¸³»°í ÀûÀýÇÑ ¾àÁ¦°¡ Àß À¯ÁöµÈ´Ù¸é Áõ»óÀÇ Å« Àç¹ß¾øÀÌ °ü¸®°¡ °¡´ÉÇÑ ÁúȯµéÀÔ´Ï´Ù. ÁúȯÀÇ °æ°ú¸¦ ±æ°Ôº¸°í ¸Õ±æ ³¡¿¡´Â ¸¶¶óÅæÀÇ µµÂøÁ¡ÀÌ ÀÖµíÀÌ ¼¼È÷ È£ÀüµÈ´Ù´Â ¹ÏÀ½À» °®°í °Ç°°ü¸®¸¦ °°ÀÌ ÇØ³ª°©½Ã´Ù.

¿¬¼¼´ë¼¼ºê¶õ½ºº´¿øÀº 1885³â H.N.¾Ë·»ÀÌ ¼¼¿î ¿ì¸®³ª¶ó ÃÖÃÊÀÇ ¼¾ç½Ä º´¿øÀÎ Á¦Áß¿ø(±¤Çý¿ø)À¸·Î ⸳µÈ ÀÌ·¡ 130³â µ¿¾È ÃÖ°íÀÇ Ã·´Ü ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Â Á¾ÇÕ ÀÇ·á±â°üÀÌ´Ù. ±¹³» ÃÖÃÊ·Î Áø·áÀÇ Àü¹®È¸¦ ÅëÇÑ ÀÇ·áÀÇ Áú Çâ»óÀ» À§ÇØ ÀçȰº´¿ø, ½ÉÀåÇ÷°üº´¿ø, ¾È.À̺ñÀÎÈİúº´¿ø, ¾î¸°À̺´¿ø°ú ÀÀ±ÞÁø·á¼¾ÅÍ, ±¹Á¦Áø·á¼¾ÅÍ µî Àü¹®¼¾ÅÍ, ¾ÏÀü¹®Å¬¸®´ÐÀ» ¿î¿µÇϰí ÀÖ´Ù.
¼¿ïƯº°½Ã ¼´ë¹®±¸ ¿¬¼¼·Î 50-1